Compare ALEMBIC PHARMA with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA AJANTA PHARMA ALEMBIC PHARMA/
AJANTA PHARMA
 
P/E (TTM) x 15.7 24.6 63.5% View Chart
P/BV x 6.2 6.8 90.9% View Chart
Dividend Yield % 0.6 0.5 119.0%  

Financials

 ALEMBIC PHARMA   AJANTA PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
AJANTA PHARMA
Mar-19
ALEMBIC PHARMA/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs6641,422 46.7%   
Low Rs412898 45.9%   
Sales per share (Unadj.) Rs208.7233.5 89.4%  
Earnings per share (Unadj.) Rs31.044.0 70.5%  
Cash flow per share (Unadj.) Rs37.152.2 71.2%  
Dividends per share (Unadj.) Rs5.509.00 61.1%  
Dividend yield (eoy) %1.00.8 131.7%  
Book value per share (Unadj.) Rs144.2255.1 56.5%  
Shares outstanding (eoy) m188.5288.02 214.2%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x2.65.0 51.9%   
Avg P/E ratio x17.426.4 65.8%  
P/CF ratio (eoy) x14.522.2 65.2%  
Price / Book Value ratio x3.74.5 82.1%  
Dividend payout %17.720.5 86.7%   
Avg Mkt Cap Rs m101,461102,081 99.4%   
No. of employees `000NA6.8 0.0%   
Total wages/salary Rs m7,4674,307 173.4%   
Avg. sales/employee Rs ThNM3,022.6-  
Avg. wages/employee Rs ThNM633.4-  
Avg. net profit/employee Rs ThNM569.1-  
INCOME DATA
Net Sales Rs m39,34720,554 191.4%  
Other income Rs m94211 44.5%   
Total revenues Rs m39,44120,765 189.9%   
Gross profit Rs m8,7365,664 154.2%  
Depreciation Rs m1,152721 159.9%   
Interest Rs m18412 1,587.1%   
Profit before tax Rs m7,4935,143 145.7%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5681,273 123.1%   
Profit after tax Rs m5,8443,870 151.0%  
Gross profit margin %22.227.6 80.6%  
Effective tax rate %20.924.8 84.5%   
Net profit margin %14.918.8 78.9%  
BALANCE SHEET DATA
Current assets Rs m19,57711,812 165.7%   
Current liabilities Rs m14,8963,776 394.5%   
Net working cap to sales %11.939.1 30.4%  
Current ratio x1.33.1 42.0%  
Inventory Days Days9077 116.0%  
Debtors Days Days4582 55.6%  
Net fixed assets Rs m27,09714,398 188.2%   
Share capital Rs m377175 214.9%   
"Free" reserves Rs m26,81122,277 120.4%   
Net worth Rs m27,18822,452 121.1%   
Long term debt Rs m4,9937 75,651.5%   
Total assets Rs m47,77826,962 177.2%  
Interest coverage x41.7444.3 9.4%   
Debt to equity ratio x0.20 62,473.3%  
Sales to assets ratio x0.80.8 108.0%   
Return on assets %12.614.4 87.6%  
Return on equity %21.517.2 124.7%  
Return on capital %23.623.0 102.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,45310,682 182.1%   
Fx outflow Rs m6,0652,102 288.5%   
Net fx Rs m13,3888,580 156.0%   
CASH FLOW
From Operations Rs m8,1203,748 216.6%  
From Investments Rs m-7,556-2,228 339.1%  
From Financial Activity Rs m590-1,475 -40.0%  
Net Cashflow Rs m1,15345 2,551.5%  

Share Holding

Indian Promoters % 74.1 73.8 100.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 1.6 187.1%  
FIIs % 9.1 7.6 119.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 17.0 81.8%  
Shareholders   49,328 20,968 235.3%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   DR. DATSONS LABS  DISHMAN PHARMA  FULFORD INDIA  ASTRAZENECA PHARMA  DIVIS LABORATORIES  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 257 Points Higher, Coal India and UPL Among Top Gainers(Closing)

Indian share markets continued their positive trend during closing hours today and ended their day on a firm note.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Penny Stock Master Series: The Quest for 10X Profits in 10 Years(Profit Hunter)

Feb 12, 2021

This is first of the three part master series. In these editorials, I'll show you how to earn 10X returns from a penny stock portfolio over 10 years.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Feb 25, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 5-YR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS